Biocoat, Inc. Announces ISO 13485:2016 Certification

Specialty manufacturer of hydrophilic biomaterial coatings for medical devices receives ISO 13485:2016 Certification after consistently meeting customer and regulatory requirements HORSHAM, PA, March 7, 2019 Biocoat, Inc., a specialty manufacturer of hydrophilic biomaterial coatings for medical devices, today announced that the company has received the certification of registration for the ISO 13485:2016 Quality Management System. The Horsham, PA-based company specializes in supplying lubricious hydrophilic coatings for medical devices used in the neurovascular, cardiovascular, peripheral, and ophthalmic markets to original equipment manufacturers and contract manufacturers. This certification process reflects a culmination of Biocoat’s ongoing commitment to ...
Read More

Biocoat, Inc. Names Steven Bell Chief Financial Officer

Bell to lead financial growth planning for leading biomaterial coatings company HORSHAM, PENN. January 23, 2019 Biocoat, Inc. announced today that Steven Bell has joined the company as Chief Financial Officer (CFO). Based in Horsham, PA, Biocoat develops and licenses biomaterial coatings for interventional medical devices that are custom engineered to meet specific clinical design parameters. “It is a pleasure to add Steve to the Biocoat leadership team on a full-time basis. Steve has been working with Biocoat on a consultant basis for the past few months and played a key role in the recent ...
Read More

Biocoat, Inc. Has Been Acquired by 1315 Capital

Specialty manufacturer of hydrophilic biomaterial coatings for medical devices has been acquired by leading healthcare growth investment firm HORSHAM, PA, January 16, 2019 Biocoat, Inc., (Biocoat) a 27-year old privately held company, announced today that it has been acquired by 1315 Capital, a Philadelphia-based healthcare investment firm that provides expansion and growth capital to commercial-stage healthcare services, medical technology, and specialty pharmaceutical companies.  The transaction closed on December 20, 2018. The acquisition of Biocoat by 1315 Capital will assist the Company in taking a more aggressive and growth-oriented approach in the biomaterial coatings market for ...
Read More

CEOCFO Magazine Interviews Jim Moran, President and CEO of Biocoat, Inc

Q&A with Jim Moran, President and CEO of Biocoat, Inc. developing and licensing Lubricious Hydrophilic Biocompatible Coatings for Interventional Medical Devices such as Guidewires, Catheters and Microcatheters Click Here To Read Full Interview ...
Read More

Biocoat, Inc. Partners with Adam Spence on an Integrated Solution to Streamline Development of Reinforced Catheters for Vascular Procedures

Partnership brings Biocoat’s hydrophilic lubricious coating technology to Adam Spence’s custom catheters and promises collaboration to improve patient experience HORSHAM, Pa. (PRWEB) August 21, 2018 A new strategic partnership between Biocoat, Inc. and Adam Spence, a Spectrum Plastics Group Company, will streamline the process of producing catheters used in vital vascular procedures, such as angioplasty, bypass surgery, fluid drainage, and other essential treatments. The partnership allows Adam Spence’s innovative reinforced catheter shafts to receive Biocoat’s industry-leading hydrophilic coatings. The two companies have also committed to sharing expertise on the development of new products to improve ...
Read More

Biocoat Names Scott Cramer As Chair Of Company’s Board of Directors

Horsham, PA (PRWEB)July 09, 2018 Biocoat, Inc. has appointed former Accriva Diagnostics President and CEO Scott Cramer as Chair of its Board of Directors. The Biocoat Board of Directors provides guidance and direction to the growing Horsham, PA-based company, which develops and licenses biomaterial coatings for medical devices that are custom engineered to meet specific clinical design parameters. “The election of Scott Cramer as Chairman of the Biocoat Board of Directors gives our growing organization a level of insight and experience that will help us achieve our aggressive growth and product development goals throughout the ...
Read More

Biocoat, Inc. names Joseph Sandora Vice President of Business Development

Sandora brings extensive business development experience to the growing biomaterial coatings company HORSHAM, PENN. (PRWEB) JUNE 11, 2018 Biocoat, Inc. announced today that Joseph Sandora has joined the company as Vice President of Business Development. Based in Horsham, PA, Biocoat develops and licenses biomaterial coatings for medical devices that are custom engineered to meet specific clinical design parameters. “We are pleased to welcome Joe Sandora to the Biocoat team. As a dedicated business and corporate development resource, Joe will lead the organization in executing our hydrophilic coating solutions growth strategy throughout the United States and Europe,” ...
Read More

Biocoat, Inc. Names Jim Moran President and CEO

Moran brings extensive medical device and startup expertise to growing biomaterial coatings company Jim Moran, President & CEO, Biocoat, Inc. HORSHAM, Pa. (PRWEB) February 15, 2018 Biocoat, Inc. announced today that Jim Moran has joined the company as president and CEO. Based in Horsham, PA, Biocoat develops and licenses biomaterial coatings for medical devices that are custom engineered to meet specific clinical design parameters. “We are excited to welcome Jim to Biocoat and to have him lead the organization through its next phase of growth. Jim’s leadership style and experience, as well as his acute ...
Read More

Biocoat, Inc. Names Robert Hergenrother Senior Director of Research and Development

Hergenrother brings extensive product development and innovation experience to growing biomaterial coatings company HORSHAM, Pa. (PRWEB) March 12, 2018 Biocoat, Inc. announced today that Robert Hergenrother, Ph.D., has joined the company as senior director, research and development. Based in Horsham, PA, Biocoat develops and licenses biomaterial coatings for medical devices that are custom engineered to meet specific clinical design parameters. In this new position, Hergenrother will oversee research and development and new product innovation for Biocoat. “Bob is an outstanding addition to our team and will play a key role in our continued growth. His ...
Read More